Fig. 5. Echocardiograms reveal no impact of VTD on cardiovascular function.
A Timeline of assessment of cardiovascular function using M-mode ultrasound throughout treatment with 0.1 mg/kg VTD QOD IP for 30 days. B–E Results from echocardiograms evaluating ejection fraction (Panel B), cardiac output (Panel C), heart rate (Panel D), and stroke volume (Panel E) showed no significant difference at any time point between VTD and control groups. Results are expressed as mean ± SEM (N = 8 per group, P > 0.05). F–I After 4 weeks of VTD treatment, no significant difference was noted for any parameter. Results are expressed as mean ± SEM (N = 8 per group, P > 0.05).